Skip to main content
Caplight Logo









Cerapedics

Cerapedics

Private
Westminster, ColoradoHealthcare & Life Scienceshttps://www.cerapedics.com/

Last Round

VC Round

Mar 23, 2022

Total Funding Raised

$106.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cerapedics is an orthobiologics company that develops and commercializes proprietary synthetic small peptide (P-15) technology platforms for bone repair and orthopedic procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthobiologicsbone graft substitutespinal fusioni-FACTORP-15 peptidesynthetic bone graftbone regenerationdrug-device combinationACDFTLIFClass III medical devicePMAFDA premarket approvalbone repairanterior cervical discectomy and fusiontransforaminal lumbar interbody fusionPearlMatrix

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cerapedics Comparables

Compare Cerapedics with similar companies based on industry and business-model similarity.

Cerapedics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kuros Biosciences AG
83%
Isto Biologics
80%
Zavation Medical Products
79%

Cerapedics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 23, 2022
VC RoundJul 13, 2018
DebtApr 19, 2017
Series DSep 29, 2016
DebtApr 7, 2015
Debt
Apr 14, 2014

Key People

Founding team and executive leadership

Valeska Schroeder

Chief Executive Officer, Chairman Of The Board, Board Member

Executive Team

Mani Gopal

Chief Operating Officer

Executive Team

Cerapedics Investors

Notable investors and investment history

Cerapedics investors
InvestorRounds
KCK MedTechVC Round
GE CapitalDebt
OrbiMedSeries B, Series C, Series A
MedImmune VenturesSeries C
Oxford FinanceDebt
NGN CapitalSeries C, Series B
Revelation PartnersSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Next-generation product evaluated in pivotal ASPIRE FDA IDE study.

  • Jan 1, 2026

    Next-generation product granted Breakthrough Device Designation by the FDA.

Cerapedics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cerapedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cerapedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWestminster, Colorado
Employee Range193
Year Founded2001
Last FundingMar 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?